Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Webinars / 2019 / Making Sense of Anti-Sense Oligo Facility Planning
Manufacture Facilities & Equipment Technology & Manufacturing

Making Sense of Anti-Sense Oligo Facility Planning

A facility’s balance between supporting initial product demand and future projections is essential.

12/11/2019 12pm EST

Sponsored By

Share

Available On-demand

csm_TMM-webinar_main_06d02b494a.png

December 11, 2019
12pm EST

One of the great advantages of solid phase Oligo synthesis is its scalability. We’ll discuss how to right-size a facility for current needs, but minimize the facility impact of an increase in manufacturing throughput to take advantage of the synthesis platform’s scalability.

Learning Objectives

  • Equip listeners to swiftly devise a facility layout using a starting batch size/throughput and a projected batch size/throughput, considering applicable code implications.

Visit Our Webinar Hub

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

Facilities & Equipment Technology & Manufacturing

December 11, 2019

Making Sense of Anti-Sense Oligo Facility Planning

Bioprocessing

October 23, 2019

Glycosylation

Facilities & Equipment Technology & Manufacturing

August 22, 2019

NextGen Now – The Future of Cell Therapy

Recommended

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.